Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in ALTA-1L Trial.
Value Health
; 27(2): 182-189, 2024 Feb.
Article
en En
| MEDLINE
| ID: mdl-37951539
Palabras clave
Anaplastic lymphoma kinase-positive nonsmall cell lung cancer; European Organisation for Research and Treatment of Cancer QLQ-30; European Organisation for Research and Treatment of Cancer QLQ-LC13; brigatinib; dyspnea scale; health-related quality of life; meaningful change threshold; nonsmall cell lung cancer; patient-reported outcomes
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Compuestos Organofosforados
/
Pirimidinas
/
Carcinoma de Pulmón de Células no Pequeñas
/
Neoplasias Pulmonares
Límite:
Humans
Idioma:
En
Revista:
Value Health
Asunto de la revista:
FARMACOLOGIA
Año:
2024
Tipo del documento:
Article